Home/Filings/4/0001104659-23-001005
4//SEC Filing

Gelone Steven P. 4

Accession 0001104659-23-001005

CIK 0001641640other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 6:08 PM ET

Size

4.8 KB

Accession

0001104659-23-001005

Insider Transaction Report

Form 4
Period: 2022-12-31
Gelone Steven P.
Chief Development Officer
Transactions
  • Tax Payment

    Ordinary Shares

    2022-12-31$1.89/sh3$614,428 total
Footnotes (1)
  • [F1]These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.

Issuer

Nabriva Therapeutics plc

CIK 0001641640

Entity typeother

Related Parties

1
  • filerCIK 0001693064

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 6:08 PM ET
Size
4.8 KB